Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Gut|June 10, 2021
Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in miceTiphaine Le Roy, Emilie Moens de Hase, Matthias Van Hul, et al.The Science of the Total Environment|May 29, 2023
Obesity promotes fumonisin B1 hepatotoxicityLéonie Dopavogui, Marion Régnier, Arnaud Polizzi, et al.Scientific Reports|December 29, 2019
Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptorCéline Lukowicz, Sandrine Ellero-Simatos, Marion Régnier, et al.Scientific Reports|March 4, 2020
Author Correction: Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptorCéline Lukowicz, Sandrine Ellero-Simatos, Marion Régnier, et al.Cell Reports|April 13, 2022
The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expressionTiffany Fougeray, Arnaud Polizzi, Marion Régnier, et al.EMBO Reports|April 27, 2026
Hepatic FGF21 is not required for fasting metabolism but guides protein appetite post energy depletionJustine Bruse, Clothilde Marbach, Arnaud Polizzi, et al.Cell Reports|June 8, 2022
ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activityAnne Fougerat, Gabriele Schoiswohl, Arnaud Polizzi, et al.Plos Biology|April 14, 2025
Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signalingMarion Régnier, Arnaud Polizzi, Tiffany Fougeray, et al.Gut|April 27, 2021
Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug targetSarra Smati, Arnaud Polizzi, Anne Fougerat, et al.Pageof 3